CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP - 21 May 2021 Form 4 Insider Report for PLURISTEM THERAPEUTICS INC (PLUR)

Role: 10%+ Owner
Signature: Clover Wolf Capital - Limited Partnership By: Clover Wolf Ltd., its General Partner /s/ Adi Wolf, Chief Executive Officer and Managing Member
Issuer symbol: PLUR
Transactions as of: 21 May 2021
Net transactions value: -$1,584,828
Form type: 4
Filing time: 27 May 2021, 06:15:01 UTC
Next filing: 01 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLUR	Common Stock	Sale	$277,955	-69,838	-1.8%	$3.98^*	3,818,026	21 May 2021	Direct
transaction	PLUR	Common Stock	Sale	$303,719	-79,300	-2.1%	$3.83^*	3,738,726	24 May 2021	Direct	F1
transaction	PLUR	Common stock	Sale	$1,003,154	-261,238	-7%	$3.84^*	3,477,488	25 May 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.78 to $3.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.65 to $4.14 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.78 to $3.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.65 to $4.14 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.